http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1302267-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aab26e539aa85ab892e1eb70ea71e9cd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 1987-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1992-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00f2e0645f59fd6acf7793dd904c0260 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25c682c0ac30d1ad50c6145f6749985c |
| publicationDate | 1992-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1302267-C |
| titleOfInvention | Oral therapeutic system having systemic action |
| abstract | 4-16040/+ Oral therapeutic system having systemic action Abstract of the Disclosure The invention relates to a therapeutic system for peroral adminis-tration and having systemic action, which system is in the form of a coated and/or laminated monocompartment system for administering carbamazepine. The therapeutic system comprises a) a wall made of a material which is permeable to water and impermeable to the components of the drug-containing core, b) a core containing finely particulate carbamazepine as drug and, as auxiliaries, a protective colloid that inhibits the crystal growth of carbamazepine in the presence of water, a swellable hydrophilic polymer and, optionally, a water-soluble compound for inducing osmosis and/or further pharmaceutically acceptable excip-ients, and c) a passageway through the wall a) for delivering the core com-ponents to the environmental body fluid. The therapeutic system can are used as anticonvulsive for the treatment of convulsive states, especially epileptic states. |
| priorityDate | 1986-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.